FDA Approves ISOTRETINOIN — Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals has announced the launch of isotretinoin, completing FDA approval following the filing of ANDA 207792. This entry into the market is positioned to intensify competition for oral isotretinoin and influence the pricing dynamics for this widely used dermatological treatment.